Interview with Patient after
High-Dose Ketamine Coma
(38-Minute Free Video)
Translation Selections:
Chinese
Deutsch
English
Español
Français
Italiano
The safety and efficacy of high dose ketamine in the treatment of RSD / CRPS are unknown. Patients who are volunteering to participate in high dose ketamine trials are placing themselves at very high
personal risk and expense.
The Food and Drug Administration (FDA) in the United States has approved ketamine as a sole anesthetic agent for general anesthesia and for the treatment of
breakthrough pain.
In this video presentation, Elizabeth Jones recounts how her recent participation in the high dose ketamine trial in June 2005 has given her a "second lease" on
life.
In the following video Elizabeth recalls the ordeal of the clinical trial in detail. Regardless of audience, the release of this video will assist in making informed
decisions about high dose
ketamine research.
SELECT BANDWIDTH FOR 38-MINUTE VIDEO:
The following videos require the free Microsoft Media Player.
If you do not have it, download it here: Microsoft Media Player
Broadband (High) ~ 352K
Broadband (Low) ~244K
Dial up with Low Bandwidth ~ 31K
Audio Only ~ 19K
Transcript of Video
Click Here For CNN Report On Ketamine Coma
For more information on RSD / CRPS, please read the Third Edition of the Clinical Practice Guidelines
GUIDELINES
The Guidelines and the above video were subject to peer review by the Foundation's Scientific
Advisory Committee
COMMITTEE
